{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-034562","form_type":"8-K","ticker":null,"cik":"0000924717","company_name":"SURMODICS INC","filed_at":"2023-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.051991+00:00","generated_at":"2026-06-13T02:38:52.574147+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Surmodics amends bylaws to tighten shareholder nomination and proxy rules","bullets":["New notice requirements for shareholder director nominees, including background info on nominee and nominating shareholder.","Company may void nominations if proxy notice under Rule 14a-19 is withdrawn, non-compliant, or unsupported by reasonable evidence.","Directors can now submit advance written consent or opposition to proposals even if absent from the meeting.","Regular board meetings date/time/place can be set by announcement at prior meeting.","Non-company proxy solicitations must use proxy cards of a color other than white; meeting conduct rules expanded."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-034562","json":"https://secwatch.observer/filing/0000950170-23-034562.json","markdown":"https://secwatch.observer/filing/0000950170-23-034562.md","text":"https://secwatch.observer/filing/0000950170-23-034562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/924717/000095017023034562/0000950170-23-034562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/924717/000095017023034562/srdx-20230720.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T02:38:52.574147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec29723bd5a1738f9fa33a9711419f7627a6858b","claim":"SURMODICS INC: Amended and restated Bylaws to update director nomination procedures, proxy solicitation rules, board meeting procedures, and shareholder meeting conduct (effective 2023-07-20).","evidence_excerpt":"On July 20, 2023, the Board of Directors of Surmodics, Inc. (the “Company”) adopted certain amendments, effective upon adoption, and restated the Bylaws of the Company (as amended, the “Restated Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/924717/000095017023034562/0000950170-23-034562-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-07-20"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}